Daewoong Pharmaceutical and LSK Global PS”Fight Son’ and Covid-19 treatment joint clinical development cooperation
Daewoong Pharmaceutical’s’Hoystar tablet’ approved for phase 3 clinical trials for COVID-19 prevention effect